Cargando…
Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
Prostate cancer (PCa) is a highly prevalent malignancy and constitutes a major cause of cancer-related morbidity and mortality. It emerges through the acquisition of genetic and epigenetic alterations. Epigenetic modifications include DNA methylation, histone modifications and microRNA deregulation....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046922/ https://www.ncbi.nlm.nih.gov/pubmed/32133274 http://dx.doi.org/10.5306/wjco.v11.i2.43 |